Cargando…
Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
IL-37 is a cytokine that plays critical protective roles in many metabolic inflammatory diseases, and its therapeutic potential has been confirmed by exogenous IL-37 administration. However, its regulatory mechanisms remain unclear. U937 cells were treated with autophagy-modifying reagents (3-MA, ch...
Autores principales: | Shi, Xiaoyi, Lai, Chunhui, Zhao, Lianyu, Zhang, Mingying, Liu, Xi, Peng, Shanqin, Guo, Weizhong, Xu, Qiuying, Chen, Song, Chen, Guang-xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035573/ https://www.ncbi.nlm.nih.gov/pubmed/32104716 http://dx.doi.org/10.1155/2020/6457879 |
Ejemplares similares
-
Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo
por: Mengke, Na-Shun, et al.
Publicado: (2016) -
IL-21 Augments Rapamycin in Expansion of Alpha Fetoprotein Antigen Specific Stem-Cell-like Memory T Cells in vitro
por: Jeza, Victor Tunje, et al.
Publicado: (2017) -
TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression
por: Cui, Guimei, et al.
Publicado: (2022) -
Chloroquine inhibits human CD4(+) T-cell activation by AP-1 signaling modulation
por: Schmidt, Ralf L. J., et al.
Publicado: (2017) -
Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium
por: Xu, Chong, et al.
Publicado: (2015)